The RESTORE consortium is comprised of 10 partners from academic translational centres, biotech industry and non-for-profit organisations in Europe. The aim of the RESTORE project is to make the transforming promise of Advanced Therapies (Cell & Gene therapies, Tissue-Engineering products, Biologised Medical Devices) a reality through the development of new Advanced Therapies and their implementation in clinical practice to enhance the value-base outcome of patients.
Key information and resources provided on the site include:
Reports:
- RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients
- D1.4 – Map of European´s ecosystem and non-European network activities for Advanced Therapies
- See MAP and list of EU ATMP facilities on page 5-7
- D2.5 – Strategy paper on viral/non-viral vector development for in vivo/ex vivo gene therapy